Effect of Hematin Administration to Patients With Protoporphyria and Liver Disease
- 1 November 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 2 (6), 817-821
- https://doi.org/10.1002/hep.1840020613
Abstract
Hepatic damage in protoporphyria appears to be caused by a toxic effect of excess protoporphyrin. Therapy which reduces the formation of excess protoporphyrin may, therefore, be helpful. We examined the effects of hematin administered i.v. to two patients with protoporphyria and decompensated cirrhosis. Neither patient had side effects from the compound or manifested signs of toxicity. The vascular disappearance of hematin in one patient was similar to that in patients with porphyria who do not have structural liver disease. In both patients, biochemical changes occurred that were compatible with a reduced rate of protoporphyrin formation. Thus, hematin administration may be useful in treating patients with protoporphyria who develop liver disease.This publication has 25 references indexed in Scilit:
- Effects of haem infusion on biliary secretion of porphyrins, haem and bilirubin in manEuropean Journal of Clinical Investigation, 1982
- Transfusion therapy in a patient with erythropoietic protoporphyriaArchives of Dermatology, 1981
- Protoporphyrin-induced Cholestasis in the Isolated In Situ Perfused Rat LiverJCI Insight, 1981
- Hematin Therapy for Acute PorphyriaMedicine, 1979
- Transitory Renal Failure Following Rapid Administration of a Relatively Large Amount of Hematin in a Patient with Acute Intermittent Porphyria in Clinical RemissionActa Medica Scandinavica, 1978
- INHERITANCE IN PROTOPORPHYRIA COMPARISON OF HÆM SYNTHETASE ACTIVITY IN SKIN FIBROBLASTS WITH CLINICAL FEATURESThe Lancet, 1976
- PORPHYRIN‐BINDING PROTEINS IN SERUM*Annals of the New York Academy of Sciences, 1975
- Fluorescing erythrocytes and porphyrin screening tests on urine, stool, and blood. Investigation of photosensitivityArchives of Dermatology, 1967
- CHOLESTYRAMINE AND PORPHYRIN-BINDINGThe Lancet, 1966
- THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS 1JCI Insight, 1945